Tenormin and Injection site induration - a phase IV clinical study of FDA data

Summary:

Injection site induration is reported as a side effect among people who take Tenormin (atenolol), especially for people who are female, 60+ old, also take Norvasc, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Injection site induration when taking Tenormin. It is created by eHealthMe based on reports of 20,083 people who have side effects when taking Tenormin from the FDA, and is updated regularly.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,474 Tenormin users. Check the latest studies of Tenormin.

What is Injection site induration?

Injection site induration is found to be associated with 554 drugs and 627 conditions by eHealthMe. Check the latest studies of Injection site induration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

20,083 people reported to have side effects when taking Tenormin.
Among them, 12 people (0.06%) have Injection site induration.

Could Tenormin cause Injection site induration?

Among these 12 people:

What is the gender of people who have Injection site induration when taking Tenormin? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Injection site induration when taking Tenormin? *

What are other drugs people take besides Tenormin? *

What are other side effects people have besides Injection site induration? *

Injection Site Pruritus (severe itching at injection site): 6 people, 50.00%
Injection Site Erythema (redness at injection site): 6 people, 50.00%
Injection Site Pain: 6 people, 50.00%
Fatigue (feeling of tiredness): 4 people, 33.33%
Injection Site Bruising: 4 people, 33.33%
Injection Site Haemorrhage (bleeding from injection site): 4 people, 33.33%
Pain In Extremity: 3 people, 25.00%
Oedema Peripheral (superficial swelling): 3 people, 25.00%
Injection Site Reaction: 3 people, 25.00%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 3 people, 25.00%

What are the existing conditions these people have? *

Wheezing (a high-pitched whistling sound made while you breath): 4 people, 33.33%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 33.33%
Broken Bone: 3 people, 25.00%
Hypersensitivity: 3 people, 25.00%
Osteoporosis (bones weak and more likely to break): 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%
Hypokalemia (low potassium): 1 person, 8.33%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 8.33%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 8.33%
Gout (uric acid crystals building up in the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tenormin and have Injection site induration?

- Check whether Injection site induration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tenormin:

Tenormin (20,474 reports)

Browse all side effects of Tenormin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site induration:

Injection site induration (554 drugs)

Browse all the conditions that are associated with Injection site induration:

Injection site induration (627 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atenolol (the active ingredients of Tenormin) and Tenormin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.